为何这队列中男性乳腺癌风险激增!只因他们都上夜班……

2021-12-02 LILYMED MedSci原创

Breast Cancer Res:挪威海上石油工人(NOPW)的男性乳腺癌风险过高:可能与极端夜班工作有关吗?

男性乳腺癌(Male breast cancer, MBC)是一种罕见的疾病,具有一些已知的危险因素,如年龄、遗传障碍、家族史、激素影响和辐射。夜班工作(NSW)扰乱昼夜节律,可能导致睡眠紊乱和性激素水平的变化,已有研究认为这会增加女护士患乳腺癌的风险。然而,对于夜班工作(NSW)和男性乳腺癌之间的关系目前仍缺乏了解。

挪威海上石油工人 (NOPW)队列成立于1998年,招募了25347名回答问卷的男性工人1965年-1998年间,每个工人都至少在挪威大陆架上的石油和天然气作业中工作过一次。所有员工都经历了为期两周的12小时工作制;只包括白班、七天和七个夜班,或只包括夜班;接下来是为期四周的工作期。夜班工作(NSW)被定义为在雇佣期间曾上夜班。

本研究组在之前报道了NOPW队列中与挪威一般人群相比的两倍多的MBC发病率(标准化发病率比[SIR]=2.18, 95%可信区间[CI] 1.13-3.81)。截至2019年12月31日,记录到的MBC病例数量从12例增加到14例,总体标准化发病率比SIRs为2.10 (95% CI 1.15-3.53),曾接触夜班工作者为2.49(1.14-4.73),从未接触过夜班工作的为1.77(0.57-4.12)。

本研究还进行了内部比较,使用根据年龄(时间尺度)和教育程度调整的Cox比例风险模型。与从未接触过夜班工作的男性相比,接触过夜班工作的男性的风险增加了33%,尽管估计数未见统计学意义(表1)。

本次报告了男性乳腺癌这一明显的职业风险,希望激励未来出现进一步的研究。在本队列中,前瞻性地记录了癌症,并对年龄和教育程度进行了对照分析。而在单独的分析中,探讨了暴露于苯和氯化脱脂剂的相关性,并没有发现增加MBC风险的迹象。生活方式因素可能会导致轮班工人患乳腺癌的风险,尽管部分影响可以通过教育作为替代变量进行调整。基于这些保留意见,我们的数据表明,极端的夜班工作可能会导致MBC风险增加

 

原文来源:

Liu et al. Excess risk of male breast cancer in the Norwegian Offshore Petroleum Workers (NOPW) cohort: a possible link to extreme night shift work? Breast Cancer Research (2021) 23:106
https://doi.org/10.1186/s13058-021-01485-w

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (15)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1764285, encodeId=c9a61e64285c2, content=<a href='/topic/show?id=967b66e9727' target=_blank style='color:#2F92EE;'>#激增#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66797, encryptionId=967b66e9727, topicName=激增)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa237702659, createdName=ms1756883563247400, createdTime=Wed Jul 27 00:55:21 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062059, encodeId=206e206205902, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Dec 22 17:55:21 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770345, encodeId=a32e1e70345e4, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Wed Oct 12 08:55:21 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590205, encodeId=c22e1590205df, content=<a href='/topic/show?id=5477e022631' target=_blank style='color:#2F92EE;'>#男性乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70226, encryptionId=5477e022631, topicName=男性乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00d17789732, createdName=tigerlr104, createdTime=Fri Dec 03 06:55:21 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076247, encodeId=324210e624725, content=待机时间, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:44 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076246, encodeId=dabe10e62469e, content=睡觉睡觉, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:41 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076245, encodeId=686610e624539, content=打家劫舍, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:37 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076244, encodeId=a14b10e62445b, content=顶焦度计, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076243, encodeId=7ca410e62433b, content=几点结束, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:30 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076242, encodeId=422110e6242e8, content=先进技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:28 CST 2021, time=2021-12-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1764285, encodeId=c9a61e64285c2, content=<a href='/topic/show?id=967b66e9727' target=_blank style='color:#2F92EE;'>#激增#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66797, encryptionId=967b66e9727, topicName=激增)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa237702659, createdName=ms1756883563247400, createdTime=Wed Jul 27 00:55:21 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062059, encodeId=206e206205902, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Dec 22 17:55:21 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770345, encodeId=a32e1e70345e4, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Wed Oct 12 08:55:21 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590205, encodeId=c22e1590205df, content=<a href='/topic/show?id=5477e022631' target=_blank style='color:#2F92EE;'>#男性乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70226, encryptionId=5477e022631, topicName=男性乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00d17789732, createdName=tigerlr104, createdTime=Fri Dec 03 06:55:21 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076247, encodeId=324210e624725, content=待机时间, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:44 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076246, encodeId=dabe10e62469e, content=睡觉睡觉, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:41 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076245, encodeId=686610e624539, content=打家劫舍, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:37 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076244, encodeId=a14b10e62445b, content=顶焦度计, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076243, encodeId=7ca410e62433b, content=几点结束, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:30 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076242, encodeId=422110e6242e8, content=先进技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:28 CST 2021, time=2021-12-02, status=1, ipAttribution=)]
    2021-12-22 sjq027
  3. [GetPortalCommentsPageByObjectIdResponse(id=1764285, encodeId=c9a61e64285c2, content=<a href='/topic/show?id=967b66e9727' target=_blank style='color:#2F92EE;'>#激增#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66797, encryptionId=967b66e9727, topicName=激增)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa237702659, createdName=ms1756883563247400, createdTime=Wed Jul 27 00:55:21 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062059, encodeId=206e206205902, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Dec 22 17:55:21 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770345, encodeId=a32e1e70345e4, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Wed Oct 12 08:55:21 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590205, encodeId=c22e1590205df, content=<a href='/topic/show?id=5477e022631' target=_blank style='color:#2F92EE;'>#男性乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70226, encryptionId=5477e022631, topicName=男性乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00d17789732, createdName=tigerlr104, createdTime=Fri Dec 03 06:55:21 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076247, encodeId=324210e624725, content=待机时间, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:44 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076246, encodeId=dabe10e62469e, content=睡觉睡觉, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:41 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076245, encodeId=686610e624539, content=打家劫舍, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:37 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076244, encodeId=a14b10e62445b, content=顶焦度计, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076243, encodeId=7ca410e62433b, content=几点结束, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:30 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076242, encodeId=422110e6242e8, content=先进技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:28 CST 2021, time=2021-12-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1764285, encodeId=c9a61e64285c2, content=<a href='/topic/show?id=967b66e9727' target=_blank style='color:#2F92EE;'>#激增#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66797, encryptionId=967b66e9727, topicName=激增)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa237702659, createdName=ms1756883563247400, createdTime=Wed Jul 27 00:55:21 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062059, encodeId=206e206205902, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Dec 22 17:55:21 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770345, encodeId=a32e1e70345e4, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Wed Oct 12 08:55:21 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590205, encodeId=c22e1590205df, content=<a href='/topic/show?id=5477e022631' target=_blank style='color:#2F92EE;'>#男性乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70226, encryptionId=5477e022631, topicName=男性乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00d17789732, createdName=tigerlr104, createdTime=Fri Dec 03 06:55:21 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076247, encodeId=324210e624725, content=待机时间, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:44 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076246, encodeId=dabe10e62469e, content=睡觉睡觉, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:41 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076245, encodeId=686610e624539, content=打家劫舍, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:37 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076244, encodeId=a14b10e62445b, content=顶焦度计, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076243, encodeId=7ca410e62433b, content=几点结束, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:30 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076242, encodeId=422110e6242e8, content=先进技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:28 CST 2021, time=2021-12-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1764285, encodeId=c9a61e64285c2, content=<a href='/topic/show?id=967b66e9727' target=_blank style='color:#2F92EE;'>#激增#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66797, encryptionId=967b66e9727, topicName=激增)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa237702659, createdName=ms1756883563247400, createdTime=Wed Jul 27 00:55:21 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062059, encodeId=206e206205902, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Dec 22 17:55:21 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770345, encodeId=a32e1e70345e4, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Wed Oct 12 08:55:21 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590205, encodeId=c22e1590205df, content=<a href='/topic/show?id=5477e022631' target=_blank style='color:#2F92EE;'>#男性乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70226, encryptionId=5477e022631, topicName=男性乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00d17789732, createdName=tigerlr104, createdTime=Fri Dec 03 06:55:21 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076247, encodeId=324210e624725, content=待机时间, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:44 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076246, encodeId=dabe10e62469e, content=睡觉睡觉, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:41 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076245, encodeId=686610e624539, content=打家劫舍, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:37 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076244, encodeId=a14b10e62445b, content=顶焦度计, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076243, encodeId=7ca410e62433b, content=几点结束, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:30 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076242, encodeId=422110e6242e8, content=先进技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:28 CST 2021, time=2021-12-02, status=1, ipAttribution=)]
    2021-12-02 ms7000000134201027

    待机时间

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1764285, encodeId=c9a61e64285c2, content=<a href='/topic/show?id=967b66e9727' target=_blank style='color:#2F92EE;'>#激增#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66797, encryptionId=967b66e9727, topicName=激增)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa237702659, createdName=ms1756883563247400, createdTime=Wed Jul 27 00:55:21 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062059, encodeId=206e206205902, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Dec 22 17:55:21 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770345, encodeId=a32e1e70345e4, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Wed Oct 12 08:55:21 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590205, encodeId=c22e1590205df, content=<a href='/topic/show?id=5477e022631' target=_blank style='color:#2F92EE;'>#男性乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70226, encryptionId=5477e022631, topicName=男性乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00d17789732, createdName=tigerlr104, createdTime=Fri Dec 03 06:55:21 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076247, encodeId=324210e624725, content=待机时间, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:44 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076246, encodeId=dabe10e62469e, content=睡觉睡觉, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:41 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076245, encodeId=686610e624539, content=打家劫舍, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:37 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076244, encodeId=a14b10e62445b, content=顶焦度计, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076243, encodeId=7ca410e62433b, content=几点结束, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:30 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076242, encodeId=422110e6242e8, content=先进技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:28 CST 2021, time=2021-12-02, status=1, ipAttribution=)]
    2021-12-02 ms7000000134201027

    睡觉睡觉

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1764285, encodeId=c9a61e64285c2, content=<a href='/topic/show?id=967b66e9727' target=_blank style='color:#2F92EE;'>#激增#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66797, encryptionId=967b66e9727, topicName=激增)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa237702659, createdName=ms1756883563247400, createdTime=Wed Jul 27 00:55:21 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062059, encodeId=206e206205902, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Dec 22 17:55:21 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770345, encodeId=a32e1e70345e4, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Wed Oct 12 08:55:21 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590205, encodeId=c22e1590205df, content=<a href='/topic/show?id=5477e022631' target=_blank style='color:#2F92EE;'>#男性乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70226, encryptionId=5477e022631, topicName=男性乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00d17789732, createdName=tigerlr104, createdTime=Fri Dec 03 06:55:21 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076247, encodeId=324210e624725, content=待机时间, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:44 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076246, encodeId=dabe10e62469e, content=睡觉睡觉, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:41 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076245, encodeId=686610e624539, content=打家劫舍, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:37 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076244, encodeId=a14b10e62445b, content=顶焦度计, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076243, encodeId=7ca410e62433b, content=几点结束, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:30 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076242, encodeId=422110e6242e8, content=先进技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:28 CST 2021, time=2021-12-02, status=1, ipAttribution=)]
    2021-12-02 ms7000000134201027

    打家劫舍

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1764285, encodeId=c9a61e64285c2, content=<a href='/topic/show?id=967b66e9727' target=_blank style='color:#2F92EE;'>#激增#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66797, encryptionId=967b66e9727, topicName=激增)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa237702659, createdName=ms1756883563247400, createdTime=Wed Jul 27 00:55:21 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062059, encodeId=206e206205902, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Dec 22 17:55:21 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770345, encodeId=a32e1e70345e4, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Wed Oct 12 08:55:21 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590205, encodeId=c22e1590205df, content=<a href='/topic/show?id=5477e022631' target=_blank style='color:#2F92EE;'>#男性乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70226, encryptionId=5477e022631, topicName=男性乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00d17789732, createdName=tigerlr104, createdTime=Fri Dec 03 06:55:21 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076247, encodeId=324210e624725, content=待机时间, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:44 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076246, encodeId=dabe10e62469e, content=睡觉睡觉, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:41 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076245, encodeId=686610e624539, content=打家劫舍, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:37 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076244, encodeId=a14b10e62445b, content=顶焦度计, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076243, encodeId=7ca410e62433b, content=几点结束, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:30 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076242, encodeId=422110e6242e8, content=先进技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:28 CST 2021, time=2021-12-02, status=1, ipAttribution=)]
    2021-12-02 ms7000000134201027

    顶焦度计

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1764285, encodeId=c9a61e64285c2, content=<a href='/topic/show?id=967b66e9727' target=_blank style='color:#2F92EE;'>#激增#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66797, encryptionId=967b66e9727, topicName=激增)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa237702659, createdName=ms1756883563247400, createdTime=Wed Jul 27 00:55:21 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062059, encodeId=206e206205902, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Dec 22 17:55:21 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770345, encodeId=a32e1e70345e4, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Wed Oct 12 08:55:21 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590205, encodeId=c22e1590205df, content=<a href='/topic/show?id=5477e022631' target=_blank style='color:#2F92EE;'>#男性乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70226, encryptionId=5477e022631, topicName=男性乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00d17789732, createdName=tigerlr104, createdTime=Fri Dec 03 06:55:21 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076247, encodeId=324210e624725, content=待机时间, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:44 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076246, encodeId=dabe10e62469e, content=睡觉睡觉, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:41 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076245, encodeId=686610e624539, content=打家劫舍, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:37 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076244, encodeId=a14b10e62445b, content=顶焦度计, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076243, encodeId=7ca410e62433b, content=几点结束, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:30 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076242, encodeId=422110e6242e8, content=先进技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:28 CST 2021, time=2021-12-02, status=1, ipAttribution=)]
    2021-12-02 ms7000000134201027

    几点结束

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1764285, encodeId=c9a61e64285c2, content=<a href='/topic/show?id=967b66e9727' target=_blank style='color:#2F92EE;'>#激增#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66797, encryptionId=967b66e9727, topicName=激增)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa237702659, createdName=ms1756883563247400, createdTime=Wed Jul 27 00:55:21 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062059, encodeId=206e206205902, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Dec 22 17:55:21 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770345, encodeId=a32e1e70345e4, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Wed Oct 12 08:55:21 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590205, encodeId=c22e1590205df, content=<a href='/topic/show?id=5477e022631' target=_blank style='color:#2F92EE;'>#男性乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70226, encryptionId=5477e022631, topicName=男性乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e00d17789732, createdName=tigerlr104, createdTime=Fri Dec 03 06:55:21 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076247, encodeId=324210e624725, content=待机时间, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:44 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076246, encodeId=dabe10e62469e, content=睡觉睡觉, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:41 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076245, encodeId=686610e624539, content=打家劫舍, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:37 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076244, encodeId=a14b10e62445b, content=顶焦度计, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:33 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076243, encodeId=7ca410e62433b, content=几点结束, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:30 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076242, encodeId=422110e6242e8, content=先进技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220719/78e45345e7a54aa7965f216022201f0f/f7c753494cda4f2f866bc9105db59a65.png, createdBy=155c5510995, createdName=ms7000000134201027, createdTime=Thu Dec 02 16:13:28 CST 2021, time=2021-12-02, status=1, ipAttribution=)]
    2021-12-02 ms7000000134201027

    先进技术

    0

相关资讯

Eur J Cancer:Rucaparib治疗BRCA1/2野生型转移性乳腺癌的疗效

小部分不携带胚系BRCA1/2突变的高LOH评分患者也可从PARP抑制剂中获益

J Clin Oncol:基于乳腺X线检查的乳腺癌风险预测人工智能模型

乳腺癌在全球女性癌症中的发病率为24.2%,位居女性癌症的首位,其中52.9%发生在发展中国家

Eur Heart J:乳腺癌患者房颤的发生率、危险因素和死亡情况

女性确诊乳腺癌后AF发生率明显更高。诊断时较高的乳腺癌分期与较高的AF风险显著相关。在新的乳腺癌诊断中,新发AF会增加1年心血管死亡率,但不会增加与乳腺癌相关的死亡率。

患者满意度研究结果来了!胸下乳房重建和胸前乳房重建哪种术式会让患者术后幸福感更高?

近年来,胸下乳房植入物在乳房重建中占主导地位,但最近更多地采用胸前乳房植入物重建。迄今为止,比较两种技术的患者报告结果的研究有限。

BMJ:乳腺癌患者术后运动对上肢功能的影响

建议乳腺癌术后患者积极接受结构化运动干预,可有效降低上肢残疾风险

2021 ACR年会:系统性红斑狼疮是老年早期乳腺癌患者死亡的危险因素

比较患有SLE和BC的女性与单独患有BC的女性或没有癌症的SLE女性的生存率。